As of January 2022, medical literature and official prescription instructions must provide detailed advice on using Ozempic (semaglutide), especially for transplant patients. However, transplant patients should exercise care when contemplating new medicines, such as Ozempic, owing to possible interactions with immunosuppressive treatments typically administered after transplantation.
.
Ozempic is a medicine used to manage type 2 diabetes. It belongs to a family of medications known as GLP-1 receptor agonists. These drugs act by increasing insulin production while decreasing blood sugar levels. While Ozempic may help manage diabetes, its safety and effectiveness in transplant patients, especially those on immunosuppressive medication, are unclear.
.
Please visit our Facebook page by clicking the link in our bio above to view the complete article.🌿
.
#TPCH #TransplantAwareness #DonateLife #lungitudefoundation #OrganAndTissueDonation #TransplantAustralia #thecommongoodau #QueenslandLungTransplantService #LungFoundationAustralia #LungsInAction #ageilityfit #amtanmedicals #DoubleLungTransplant #LungTransplant #PulmonaryFibrosis #PulmonaryRehab #InterstitialLungDisease #OrganDonor #LungDisease #TheGiftOfLife #itonlytakesaminute #DonateALife #Registertoday #talktoyourfamily #lunghealthaustralia #EveryBreathSheTakes #JerseyDayAU🌿
.
Disclaimer:
The content covers organ and tissue donation and transplantation within Australia and is for information only, and does not replace medical advice. You should not rely on this information as a substitute for, nor does it replace, professional services, medical advice, diagnosis, or treatment. The content is to help raise awareness of the need for organ and tissue donation and the benefits of transplantation. I have made every reasonable effort to ensure the correctness of the information provided but do not guarantee any item. If you have any concerns or questions about your health, you should always consult a healthcare professional or your transplant team.


Source